Drug intelligence / Profile preview

silver zinc sulfadiazine

Development stage
Unknown
Lead developer
Chulalongkorn University
Modality
Small Molecules
Administration
Topical
01

Overview

Silver zinc sulfadiazine is a topical antimicrobial agent primarily used for the prevention and treatment of wound sepsis in patients with second- and third-degree burns, including partial-thickness burn wounds. It is a combination therapy that integrates the broad-spectrum bactericidal properties of silver sulfadiazine with the wound-healing benefits of zinc. The silver component releases ions into the wound environment that disrupt bacterial cell membranes and bind to microbial DNA, thereby inhibiting bacterial replication and protein synthesis. The zinc component serves as a cofactor for various enzymes involved in tissue repair, promoting epithelialization and accelerating the overall healing process. It is typically formulated as a 1% cream and is often used as a standard of care or comparator in clinical trials evaluating new wound-healing therapies.

Other names
silver-zinc sulfadiazineSZSsilver zinc sulfadiazine cream
02

Targets

NeuraminidaseDHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on silver zinc sulfadiazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on silver zinc sulfadiazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call